adalimumab-adbm (Cyltezo)

From Aaushi
Jump to navigation Jump to search
[1]

Introduction

Biosimilar to adalimumab. FDA-approved August. 2017

More general terms

References

  1. ↑ Brooks M FDA Approves Second Humira Biosimilar, Cyltezo Medscape - Aug 25, 2017. http://www.medscape.com/viewarticle/884735
Retrieved from "https://aaushi.info/w/index.php?title=A491020&oldid=1192033"